Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exocrine Pancreatic Carcinoma”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Not applicableActive Not RecruitingNCT06815172
What this trial is testing

PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.

Who this might be right for
Pancreatic Adenocarcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 500
Not applicableLooking for participantsNCT07396662
What this trial is testing

Endocrine-exocrine Functions and Prognosis After Pancreatectomy

Who this might be right for
Pancreatic Neoplasm
National Taiwan University Hospital 3,500
Testing effectiveness (Phase 2)Study completedNCT03738787
What this trial is testing

Treatment of the Pancreatic Stump With Neoprene®-Based Glue After High-risk Pancreatoduodenectomy

Who this might be right for
Pancreatic FistulaPancreatic NeoplasmsPostoperative Complications
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Testing effectiveness (Phase 2)Active Not RecruitingNCT03485209
What this trial is testing

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Who this might be right for
Colorectal NeoplasmsCarcinoma, Non-Small-Cell LungExocrine Pancreatic Cancer+1 more
Seagen, a wholly owned subsidiary of Pfizer 350
Not applicableLooking for participantsNCT06651580
What this trial is testing

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Who this might be right for
Chronic PancreatitisExocrine Pancreas CarcinomaRecurrent Acute Pancreatitis
M.D. Anderson Cancer Center 1,600
Early research (Phase 1)Ended earlyNCT03957096
What this trial is testing

A Safety Study of SGN-CD47M in Patients With Solid Tumors

Who this might be right for
Soft Tissue SarcomaColorectal CancerHead and Neck Squamous Cell Carcinoma+6 more
Seagen Inc. 16
Post-approval studies (Phase 4)WithdrawnNCT04315311
What this trial is testing

Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer

Who this might be right for
Exocrine Pancreatic Insufficiency (EPI)
AbbVie
Early research (Phase 1)Study completedNCT00220649
What this trial is testing

Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Neoplasms
St. Luke's-Roosevelt Hospital Center 25
Post-approval studies (Phase 4)Ended earlyNCT03859869
What this trial is testing

Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)

Who this might be right for
Exocrine Pancreatic Insufficiency (EPI)
AbbVie 1
Very early researchEnded earlyNCT04930991
What this trial is testing

High Dose Omeprazole in Patients With Pancreatic Cancer

Who this might be right for
Exocrine Pancreatic Cancer
University of Oklahoma 25
Not applicableUnknownNCT05980221
What this trial is testing

The Development of a Metabolomic Test to Diagnose and Quantify Pancreatic Exocrine Insufficiency (The DETECTION Study)

Who this might be right for
Pancreatic Exocrine Insufficiency
University Hospital Birmingham NHS Foundation Trust 150
Not applicableStudy completedNCT05450627
What this trial is testing

Registry of Pancreatic Exocrine Insufficiency: Enzyme Dose Requirements and Outcomes in Pancreatic Exocrine Insufficiency Across Aetiologies

Who this might be right for
Exocrine Pancreatic Insufficiency
Hospital Clinico Universitario de Santiago 1,015
Large-scale testing (Phase 3)Study completedNCT00023972
What this trial is testing

Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Daiichi Sankyo
Testing effectiveness (Phase 2)Study completedNCT01020006
What this trial is testing

Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine

Who this might be right for
Pancreatic CancerDuctal AdrenocarcinomaExocrine Pancreatic Cancer
Pharmacyclics LLC. 42
Early research (Phase 1)Study completedNCT01918644
What this trial is testing

Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer

Who this might be right for
Stage IA Pancreatic CancerStage IB Pancreatic CancerStage IIA Pancreatic Cancer+1 more
University of Wisconsin, Madison 21
Not applicableUnknownNCT04112836
What this trial is testing

Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerExocrine Pancreatic InsufficiencyMetastatic Pancreatic Cancer+3 more
Moscow Clinical Scientific Center 186
Testing effectiveness (Phase 2)Active Not RecruitingNCT05554367
What this trial is testing

Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial

Who this might be right for
Exocrine Pancreas CarcinomaMalignant Solid NeoplasmOvarian Low Grade Serous Adenocarcinoma+2 more
National Cancer Institute (NCI) 199
Testing effectiveness (Phase 2)Ended earlyNCT03822936
What this trial is testing

Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma

Who this might be right for
Cancer of PancreasPancreas AdenocarcinomaResectable Pancreatic Cancer
CNAO National Center of Oncological Hadrontherapy 30
Early research (Phase 1)Study completedNCT01385956
What this trial is testing

SOM 230 and Gemcitabine in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 20
Next Page